Barclays · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
Barclays Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 879K | $343,634 | — |
| 2024Q2 | 1.4M | $416,296 | +21.1% |
| 2024Q3 | 3.0M | $918,576 | +120.7% |
| 2024Q4 | 1.3M | $364,720 | -60.3% |
| 2025Q1 | 1.4M | $421,852 | +15.7% |
| 2025Q2 | 10.8M | $790,266 | +87.3% |
| 2025Q3 | 1.6M | $312M | +39341.3% |
| 2025Q4 | 9.8M | $811M | +160.1% |
| 2026Q1 | 15.9M | $4.2B | +422.7% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F